Theriva Biologics, Inc. Share-based Payment Arrangement, Expense
Theriva Biologics, Inc. (TOVX) reported Share-based Payment Arrangement, Expense of $117.50 thousand for the 12-month period ending 2013-12-31, per its 10-Q filed 2014-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2014-05-15
- Theriva Biologics, Inc. share-based payment arrangement, expense for the quarter ending 2012-09-30 was $395.00K, a 558.33% increase year-over-year.
- Theriva Biologics, Inc. share-based payment arrangement, expense for the quarter ending 2012-06-30 was $400.00K, a 601.75% increase year-over-year.
- Theriva Biologics, Inc. share-based payment arrangement, expense for the quarter ending 2011-09-30 was $60.00K.
- Theriva Biologics, Inc. share-based payment arrangement, expense for the quarter ending 2011-06-30 was $57.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2013-12-31 | $117.50K 10-Q · filed 2014-05-15 | |||
| 2012-09-30 | $395.00K 10-Q · filed 2012-11-14 | $795.00K derived: sum of 2 quarters · filed 2012-11-14 | $1.30M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $400.00K 10-Q/A · filed 2012-09-11 | $908.00K 10-Q/A · filed 2012-09-11 | ||
| 2011-09-30 | $60.00K 10-Q · filed 2012-11-14 | $117.00K derived: sum of 2 quarters · filed 2012-11-14 | $894.00K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $57.00K 10-Q/A · filed 2012-09-11 | $427.00K 10-Q/A · filed 2012-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |